ZoneOne Pharma


ZoneOne Pharma
San Francisco, CA

Residents
ZoneOne Pharma

Z1P was formed with the intent to bring rationally designed new liposome products to market to treat chronic orphan diseases. We select product candidates for diseases that have a significant unmet clinical need and have well-understood chemistry and biology. This enables quantitative clinical endpoints and efficient clinical trial design. Our proprietary delivery systems can offer superior dosing and compliance benefits over existing products.